Mettler-Toledo (MTD) CFO discloses 300-share buy/sell and 300 options
Rhea-AI Filing Summary
Insider transactions by Mettler-Toledo CFO Shawn Vadala reported on Form 4 show offsetting trades on 08/19/2025. The filing records an acquisition and a disposition of the same quantity of common stock: 300 shares reported as acquired at $397.95 and 300 shares reported as disposed at $1,325. After those non-derivative transactions the reporting person’s common stock holdings are listed as 5,395 shares then 5,095 shares respectively. The filing also reports a derivative transaction the same date: 300 stock options with an exercise/conversion price of $397.95, exercisable from 11/03/2017 and expiring 11/03/2026, leaving 300 underlying shares from that option and total derivative holdings of 1,145 shares. The form is signed by an attorney-in-fact on 08/21/2025.
Positive
- Form filed and signed with attorney-in-fact signature (Michelle M. Roe) and dates provided
- Detailed disclosure of both non-derivative and derivative transactions with quantities, prices, exercisability, and expiration
Negative
- None.
Insights
TL;DR: The company’s CFO reported contemporaneous acquisition and sale of 300 shares plus a derivative option entry, indicating routine insider transactions.
The Form 4 documents non-derivative and derivative transactions executed on 08/19/2025 by Shawn Vadala, CFO. The non-derivative lines show 300 shares acquired at $397.95 and 300 shares sold at $1,325, with resulting direct common stock holdings reported as 5,395 then 5,095 shares. The derivative table records a transaction of 300 stock options with a stated exercise/conversion price of $397.95 and an expiration date of 11/03/2026, and reports 1,145 derivative shares beneficially owned after the transaction. All information is presented as reported on the Form 4; no additional context about intent, tax planning, or trading program is provided in the filing.
TL;DR: Reporting is complete and signed; transactions appear documented for a single reporting person with attorney-in-fact signature.
The filing identifies Shawn Vadala as both an officer (Chief Financial Officer) and the reporting person. It is filed as a Form 4 by one reporting person and includes an attorney-in-fact signature (Michelle M. Roe) dated 08/21/2025. The filing lists both non-derivative and derivative securities activity on the same transaction date, and provides the specific amounts and prices as required. The explanatory note clarifies a vesting schedule for the options (annual five equal installments beginning first anniversary of grant), which is stated in the filing. No governance irregularities or missing signatures are evident within the document text provided.